What are the clinical criteria for common ENT conditions such as acute bacterial sinusitis, acute otitis media, streptococcal pharyngitis, and Meniere disease?

ENT Clinical Criteria

The diagnosis of common ENT conditions relies on specific clinical criteria that distinguish bacterial from viral infections, with acute bacterial sinusitis requiring symptoms persisting ≥10 days or "double worsening," streptococcal pharyngitis requiring laboratory confirmation, and acute otitis media requiring direct visualization of a bulging, purulent tympanic membrane.

Acute Bacterial Rhinosinusitis (ABRS)

Diagnostic Criteria

Diagnose ABRS when patients present with purulent nasal drainage (anterior, posterior, or both) plus nasal obstruction, facial pain-pressure-fullness, or both, AND meet one of these temporal patterns 1, 2:

1. Persistent symptoms: ≥10 days without improvement
2. Double worsening: Initial improvement followed by worsening within 10 days (new fever, increased discharge, or worsening cough)
3. Severe onset: High fever (≥39°C) plus purulent nasal discharge for at least 3-4 consecutive days 3

Critical Distinction from Viral Rhinosinusitis

• Viral rhinosinusitis: Symptoms <10 days and NOT worsening 1, 2
• Key pitfall: Facial pain alone without purulent discharge is insufficient for diagnosis 1

Imaging

Do not obtain imaging for uncomplicated ABRS—diagnosis is purely clinical 1, 2. Reserve CT/MRI for suspected complications (orbital involvement, intracranial extension).

Streptococcal Pharyngitis

Clinical Screening Criteria

Test only when ≥2 of the following are present 4, 5:

• Fever
• Tonsillar exudate or swelling
• Tender anterior cervical lymphadenopathy
• Absence of cough

Diagnostic Requirements

Laboratory confirmation is mandatory—clinical diagnosis alone is unreliable even with all features present (only 35-50% accuracy) 5. Use rapid antigen detection test (RADT) or throat culture 5.

Critical Pitfalls

• Never treat empirically without testing (except household contact with confirmed GAS) 4
• Do not test children <3 years—GAS pharyngitis is rare in this age group 4
• Up to 15-20% of asymptomatic children are carriers; indiscriminate testing leads to inappropriate treatment 4, 6

Acute Otitis Media (AOM)

Diagnostic Criteria

AOM is a visual diagnosis requiring pneumatic otoscopy demonstrating 6:

• Bulging tympanic membrane
• Purulent middle ear effusion
• Acute inflammation (erythema)
• Middle ear effusion with impaired mobility

History alone is insufficient for diagnosis 6, 7. The pneumatic otoscope is the standard diagnostic tool.

Key Distinctions

• Otitis media with effusion: Fluid present but no acute inflammation—does NOT require antibiotics
• Congestive otitis: Erythema without effusion—does NOT require antibiotics 8

Meniere Disease

The provided evidence does not contain specific diagnostic criteria for Meniere disease. This condition requires specialist evaluation with audiometry and vestibular testing, typically diagnosed by recurrent episodes of vertigo (20 minutes to 12 hours), fluctuating sensorineural hearing loss, tinnitus, and aural fullness.

Management Algorithm for ABRS

For patients meeting ABRS criteria 2, 3:

1. Assess severity and risk factors:

   • Risk factors: Age <2 or >65, recent antibiotics (past month), daycare, comorbidities, immunocompromised 3

2. Initial management:

   • Without risk factors: Watchful waiting (7 days) OR amoxicillin with or without clavulanate 1, 2
   • With risk factors or severe symptoms: Amoxicillin-clavulanate immediately 2, 3

3. Reassess at 3-5 days:

   • No improvement: Broaden coverage or switch antibiotic class
   • Worsening: Consider imaging for complications, refer to specialist 3

First-Line Antibiotic

Amoxicillin with or without clavulanate for 5-10 days 1, 2. The 2025 guideline changed from amoxicillin alone to include clavulanate as first-line due to evolving resistance patterns 2.

Management for Streptococcal Pharyngitis

If RADT or culture positive: Treat with amoxicillin or penicillin 4, 5. Benefits include shortened symptom duration, prevention of rheumatic fever, and reduced transmission 4.